Twin Focus Capital Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Twin Focus Capital Partners's IDXX Position: Q1 2026 in Review
Twin Focus Capital Partners sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 440 shares — an estimated $298K sold.
Twin Focus Capital Partners first reported a position in IDXX in Q4 2020 and held it in 18 quarters. The position peaked at $560K in Q4 2021. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Twin Focus Capital Partners reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Twin Focus Capital Partners sold 440 Idexx Laboratories shares in Q1 2026, an estimated $298K.
- Twin Focus Capital Partners first reported a position in Idexx Laboratories in Q4 2020 and held it in 18 quarters.
- Twin Focus Capital Partners's Idexx Laboratories position peaked at $560K in Q4 2021.
- 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Twin Focus Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.